Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Nucleic Acid Isolation and Purification Market, by Application
1.4.2 North America Nucleic Acid Isolation and Purification Market, by Product
1.4.3 North America Nucleic Acid Isolation and Purification Market, by Method
1.4.4 North America Nucleic Acid Isolation and Purification Market, by Type
1.4.5 North America Nucleic Acid Isolation and Purification Market, by End User
1.4.6 North America Nucleic Acid Isolation and Purification Market, by Country
1.5 Methodology for the research
Chapter 2. Market At a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.3 Market Share Analysis, 2022
4.4 Top Winning Strategies
4.4.1 Key Leading Strategies: Percentage Distribution (2019-2023)
4.4.2 Key Strategic Move: (Product Launches and Product Expansions: 2021, Mar – 2023, Oct) Leading Players
4.5 Porter’s Five Forces Analysis
Chapter 5. North America Nucleic Acid Isolation and Purification Market by Application
5.1 North America Diagnostics Market by Country
5.2 North America Drug Discovery & Development Market by Country
5.3 North America Agriculture & Animal Research Market by Country
5.4 North America Personalized Medicine & Others Market by Country
Chapter 6. North America Nucleic Acid Isolation and Purification Market by Product
6.1 North America Reagents Market by Country
6.2 North America Kits Market by Country
6.3 North America Instruments Market by Country
Chapter 7. North America Nucleic Acid Isolation and Purification Market by Method
7.1 North America Magnetic Beads Market by Country
7.2 North America Column Based Market by Country
7.3 North America Reagent Based Market by Country
7.4 North America Others Market by Country
Chapter 8. North America Nucleic Acid Isolation and Purification Market by Type
8.1 North America Plasmid DNA Isolation & Purification Market by Country
8.2 North America Total RNA Isolation & Purification Market by Country
8.3 North America Circulating Nucleic Acid Isolation & Purification Market by Country
8.4 North America Genomic DNA Isolation & Purification Market by Country
8.5 North America Messenger RNA Isolation & Purification Market by Country
8.6 North America microRNA Isolation & Purification Market by Country
8.7 North America Others Market by Country
Chapter 9. North America Nucleic Acid Isolation and Purification Market by End User
9.1 North America Hospitals & Diagnostic Centers Market by Country
9.2 North America Pharmaceutical & Biotechnology Companies Market by Country
9.3 North America Academic Research Institutes Market by Country
9.4 North America Contract Research Organizations Market by Country
9.5 North America Others Market by Country
Chapter 10. North America Nucleic Acid Isolation and Purification Market by Country
10.1 US Nucleic Acid Isolation and Purification Market
10.1.1 US Nucleic Acid Isolation and Purification Market by Application
10.1.2 US Nucleic Acid Isolation and Purification Market by Product
10.1.3 US Nucleic Acid Isolation and Purification Market by Method
10.1.4 US Nucleic Acid Isolation and Purification Market by Type
10.1.5 US Nucleic Acid Isolation and Purification Market by End User
10.2 Canada Nucleic Acid Isolation and Purification Market
10.2.1 Canada Nucleic Acid Isolation and Purification Market by Application
10.2.2 Canada Nucleic Acid Isolation and Purification Market by Product
10.2.3 Canada Nucleic Acid Isolation and Purification Market by Method
10.2.4 Canada Nucleic Acid Isolation and Purification Market by Type
10.2.5 Canada Nucleic Acid Isolation and Purification Market by End User
10.3 Mexico Nucleic Acid Isolation and Purification Market
10.3.1 Mexico Nucleic Acid Isolation and Purification Market by Application
10.3.2 Mexico Nucleic Acid Isolation and Purification Market by Product
10.3.3 Mexico Nucleic Acid Isolation and Purification Market by Method
10.3.4 Mexico Nucleic Acid Isolation and Purification Market by Type
10.3.5 Mexico Nucleic Acid Isolation and Purification Market by End User
10.4 Rest of North America Nucleic Acid Isolation and Purification Market
10.4.1 Rest of North America Nucleic Acid Isolation and Purification Market by Application
10.4.2 Rest of North America Nucleic Acid Isolation and Purification Market by Product
10.4.3 Rest of North America Nucleic Acid Isolation and Purification Market by Method
10.4.4 Rest of North America Nucleic Acid Isolation and Purification Market by Type
10.4.5 Rest of North America Nucleic Acid Isolation and Purification Market by End User
Chapter 11. Company Profiles
11.1 Thermo Fisher Scientific, Inc.
11.1.1 Company Overview
11.1.2 Financial Analysis
11.1.3 Segmental and Regional Analysis
11.1.4 Research & Development Expenses
11.1.5 Recent strategies and developments:
11.1.5.1 Partnerships, Collaborations, and Agreements:
11.1.5.2 Product Launches and Product Expansions:
11.1.6 SWOT Analysis
11.2 Qiagen N.V.
11.2.1 Company Overview
11.2.2 Financial Analysis
11.2.3 Regional Analysis
11.2.4 Research & Development Expense
11.2.5 Recent strategies and developments:
11.2.5.1 Product Launches and Product Expansions:
11.2.5.2 Acquisition and Mergers:
11.2.5.3 Geographical Expansions:
11.2.6 SWOT Analysis
11.3 F. Hoffmann-La Roche Ltd.
11.3.1 Company Overview
11.3.2 Financial Analysis
11.3.3 Segmental and Regional Analysis
11.3.4 Research & Development Expense
11.3.5 Recent strategies and developments:
11.3.5.1 Partnerships, Collaborations, and Agreements:
11.3.5.2 Product Launches and Product Expansions:
11.3.6 SWOT Analysis
11.4 Merck KGaA
11.4.1 Company Overview
11.4.2 Financial Analysis
11.4.3 Segmental and Regional Analysis
11.4.4 Research & Development Expense
11.4.5 SWOT Analysis
11.5 Promega Corporation
11.5.1 Company Overview
11.5.2 Recent strategies and developments:
11.5.2.1 Partnerships, Collaborations, and Agreements:
11.5.2.2 Product Launches and Product Expansions:
11.5.3 SWOT Analysis
11.6 Agilent Technologies, Inc.
11.6.1 Company Overview
11.6.2 Financial Analysis
11.6.3 Segmental and Regional Analysis
11.6.4 Research & Development Expense
11.6.5 SWOT Analysis
11.7 Danaher Corporation
11.7.1 Company Overview
11.7.2 Financial Analysis
11.7.3 Segmental and Regional Analysis
11.7.4 Research & Development Expense
11.7.5 SWOT Analysis
11.8 Bio-Rad laboratories, Inc.
11.8.1 Company Overview
11.8.2 Financial Analysis
11.8.3 Segmental and Regional Analysis
11.8.4 Research & Development Expenses
11.8.5 Recent strategies and developments:
11.8.5.1 Product Launches and Product Expansions:
11.8.5.2 Acquisition and Mergers:
11.8.6 SWOT Analysis
11.9 Illumina, Inc.
11.9.1 Company Overview
11.9.2 Financial Analysis
11.9.3 Regional Analysis
11.9.4 Research & Development Expense
11.9.5 SWOT Analysis
11.10. New England Biolabs, Inc.
11.10.1 Company Overview
11.10.2 SWOT Analysis
Unique Offerings 